Malaria Vaccine Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2022-30

1
Global Malaria Vaccine Market Research and
Forecast Report 2022-2030




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Malaria Vaccine Market Research Report
2022-2030 According to the latest report by
IMARC Group, titled "Malaria Vaccine Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2022-2030," the global
malaria vaccine market is expected to exhibit a
CAGR of around 34 during 2022-2030. Malaria
vaccines are biological components that promote
the formation of antibodies to reduce the risk of
developing malaria, a disease caused by the
plasmodium parasite, which is spread to humans
through the bites of infected mosquitoes. It is
generally characterized by headaches, chills,
fever, fatigue, nausea, and other symptoms.
Some commonly used malaria vaccines include
pre-erythrocytic, erythrocytic, and multi-antigen
vaccines. They can be administered through
intramuscular, subcutaneous, and intradermal
injections. In recent years, malaria vaccines
have gained immense traction across the globe to
prevent the risk of contracting malaria.
Request for a PDF sample of this report
https//www.imarcgroup.com/malaria-vaccine-market/
requestsample

4
Report Description and Highlights
Report Description
Global Malaria Vaccine Market Trends The
rising prevalence of malaria, especially across
tropical countries, represents the primary factor
driving the market growth. Moreover, the
development of anti-infective or pre-erythrocytic
vaccines that kill the plasmodium parasite and
prevent the progression of chronic blood-stage
disorders is positively influencing market
growth. Additionally, numerous favorable
initiatives by various government and
non-government organizations to spread awareness
about the importance of immunization and disease
prevention among the masses are other major
growth-inducing factors. Along with this, the
increasing number of routine immunization
programs in various countries, particularly in
the endemic and rural regions, is propelling the
market growth. Besides this, the rising focus of
pharmaceutical companies on the development of
new and improved malaria vaccines by accelerating
the clinical trials of various pipeline drugs has
catalyzed market growth. Furthermore, numerous
technological advancements, including the
introduction of novel adjuvants and innovative
vaccination delivery platforms, are contributing
to the market growth. Other factors, including
ongoing research and development (RD)
activities, the launch of innovative product
variants, extensive investments in improving
healthcare infrastructure, and increasing funding
for vaccine development programs, are also
anticipated to create a favorable market
outlook. View Report TOC, Figures and Tables
https//www.imarcgroup.com/malaria-vaccine-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Type
• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-Antigen Vaccine
• Others
•  
• Breakup by Agent
• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species
• Breakup by Route of Administration
• Intramuscular
• Subcutaneous
• Intradermal
• Others

6
Report Description and Highlights
Report Description

• Breakup by Distribution Channel
• NGO/Non-Profit Organization
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

7
Key Questions Answered in the Report
Report Description

• How has the global malaria vaccine market
  performed so far and how will it perform in the
  coming years?
• What are the key regional markets?
• What is the breakup of the market based on the
  type?
• What is the breakup of the market based on the
  agent?
• What is the breakup of the market based on the
  route of administration?
• What is the breakup of the market based on the
  distribution channel?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global malaria
  vaccine market and who are the key players?
• What is the degree of competition in the
  industry?
•  

8
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Malaria Vaccine
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Market Forecast 6
   Market Breakup by Type

9
Table of Contents
Report Description
    6.1    Pre-Erythrocytic Vaccine    6.2  
 Erythrocytic Vaccine    6.3    Multi-Antigen
Vaccine     6.4    Others7    Market Breakup by
Agent    7.1    Plasmodium Falciparum    7.2  
 Plasmodium Vivax    7.3    Anopheles Species 8
   Market Breakup by Route of Administration   
8.1    Intramuscular    8.2    Subcutaneous   
8.3    Intradermal     8.4    Others 9    Market
Breakup by Distribution Channel    9.1  
 NGO/Non-Profit Organization     9.2    Hospital
Pharmacy    9.3    Retail Pharmacy Click here
to visit the complete table of content with list
of figures and tables https//www.imarcgroup.com/
malaria-vaccine-market/toc

10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
13

Contact Us